Latest AI and machine learning research in skin cancer for healthcare professionals.
Triple-negative breast cancer (TNBC) is classified as an immunologically cold tumor, which markedly weakens the therapeutic efficacy of immune checkpoint blockade (ICB) represented by anti-PD-L1 therapy. To overcome this limitation, an astragalus polysaccharide (APS)-based thermoresponsive hydrogel loaded with a β-elemene (ELE) nanoemulsion (ELE-NE-gel) was developed in this study with the aim of ...
BACKGROUND: A major challenge facing prostate cancer (PCa) cells is oxidative stress, yet the precise role and underlying mechanisms remain inadequately elucidated. The study sought to investigate the association between oxidative stress and PCa prognosis, as well as to identify potential regulatory pathways involved. METHODS: Oxidative stress-related genes and data were sourced from the Genecards...
Recent advances in dermoscopic imaging have expanded diagnostic capabilities beyond conventional contact devices. Non-contact modalities, including sh...
BACKGROUND: Prostate cancer (PCa) is a prevalent urological malignancy in men, with bone metastasis occurring in the majority of patients, often leadi...
Melanoma is one of the most aggressive forms of skin cancer, and its early detection from dermoscopic images remains a significant clinical challenge....
To develop and deploy a publicly accessible online risk estimation tool for cutaneous melanoma that prioritizes high recall to minimize missed diagnos...
BACKGROUND: First-line treatment of gastric cancer is evolving with the integration of immune checkpoint inhibitors (ICIs) and targeted agents, compli...
BACKGROUND: KRAS-mutant lung adenocarcinoma (LUAD) is associated with aggressive phenotypes and therapy resistance, which highlights an urgent need to...
Quantitative systems pharmacology (QSP) models support model-informed drug development but are computationally expensive, limiting workflows requiring...
BACKGROUND: Neoantigens-tumor-specific peptides generated by somatic mutations-are central targets of effective anticancer T cell immunity and underpi...
BACKGROUNDS: Breast cancer (BRCA) represents the most prevalent malignancy globally, with projections indicating 3.2 million new cases anticipated by ...
BACKGROUND: Colorectal cancer (CRC) is a prevalent malignant tumor with increasing incidence and mortality rates worldwide. Exosomes are secretory ves...
BACKGROUND: Hepatocellular carcinoma (HCC) is a highly lethal malignancy with poor prognosis, and effective biomarkers for predicting immunotherapy re...
Advances presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlight a shift from standalone artificial intelligenc...
BACKGROUND: The combination of immune checkpoint inhibitors (ICIs) and anti-angiogenic agents represents the standard first-line therapy for patients ...
Messenger RNA-lipid nanoparticle (mRNA-LNP) therapeutics have emerged as a versatile drug modality, enabling in vivo protein expression for vaccines, ...
BACKGROUND: Regulated cell death programs influence melanoma progression and antitumor immunity, yet a robust prognostic model integrating multiple ce...
Oncolytic viruses (OVs) represent a versatile platform for cancer immunotherapy, capable of selectively infecting and lysing tumor cells while trigger...
The 17th Annual Frontiers in Cancer Science (FCS) conference (2025) highlighted the convergence of multiomics, computational biology, and ancestry-spe...
OBJECTIVE: Lung adenocarcinoma (LUAD) molecular heterogeneity limits traditional prognostic models. Given the emerging role of neural regulation (NR) ...